Myotonic dystrophy type 1 coexisting with myasthenia gravis and thymoma
โ Scribed by Timothy Feyma; Gregory T. Carter; Michael D. Weiss
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 223 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Myotonic dystrophy type 1 (DM1) is an autosomalโdominant multisystemic disorder that may rarely be associated with benign and malignant neoplasms. Cases of both thymoma and myasthenia gravis in association with DM1 are extremely rare. A literature review revealed only three prior reports. We present a 51โyearโold man with a family history of DM1 and fluctuating diplopia and ptosis, who was found to have acetylcholine receptorโbinding antibodies, thymoma, and a clinical presentation compatible with ocular myasthenia gravis as well as positive genetic testing for DM1. Needle electromyographic (EMG) study demonstrated diffuse runs of myotonic discharges in multiple muscles, consistent with the diagnosis of DM1. Singleโfiber EMG showed both increased jitter and blocking. Due to somatic instability, which has been shown previously in DM1, the myotonin protein kinase (DMPK) gene appears to act as a tumor suppressor. Therefore, abnormal CTG repeat expansions in the gene could lead to the development of thymoma and myasthenia gravis. Muscle Nerve 38: 916โ920, 2008
๐ SIMILAR VOLUMES
## Abstract A man with spinal and bulbar muscular atrophy (SBMA) had a short (CTG)n expansion in the myotonic dystrophy protein kinase gene as well as (CAG)n expansion in the androgen receptor gene in leukocytes. The patient had the characteristic clinical findings of SBMA, but none of myotonic dys
## Abstract Creatine monohydrate (CrM) supplementation may increase strength in some types of muscular dystrophy. A recent study in myotonic muscular dystrophy type 1 (DM1) did not find a significant treatment effect, but measurements of muscle phosphocreatine (PCr) were not performed. We completed